Home › Endometrial Cancer › Arkansas › Little Rock
Endometrial Cancer clinical trials in Little Rock, AR
10 studies for Endometrial Cancer are looking for participants at sites in and around Little Rock (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- University of Arkansas for Medical Sciences, Little Rock
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- University of Arkansas Medical School, Little Rock
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
RecruitingPhase 1
- University of Arkansas Winthrop P. Rockefeller Cancer Institute, Little Rock
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RecruitingPhase 3
- Research Site, Little Rock
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RecruitingPhase 2
- University of Arkansas for Medical Sciences, Little Rock
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
RecruitingPhase 1
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RecruitingPhase 1
- University of Arkansas, Little Rock
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
RecruitingPhase 2
- Michael Birrer, MD, PhD, Little Rock
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Little Rock
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Columbus, OH25 studies
- Chicago, IL25 studies
- Oklahoma City, OK25 studies
Other studies in Little Rock
- Schizophrenia19 studies
- Cancer (all types)14 studies
- Major Depressive Disorder14 studies
- Acute Myeloid Leukemia13 studies
- Non-Small Cell Lung Cancer13 studies
- Obesity11 studies
- Depression10 studies
- Type 2 Diabetes10 studies
- Lung Cancer9 studies
- Cardiovascular Disease9 studies
- Bladder Cancer9 studies
- Heart Failure9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.